Bundled Cancer Screening and Genetic Services Navigation
NCT07228000
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Breast Cancer Screening
- Colon Cancer Screening
- Genetics Predisposition
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 45 to 74 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Georgetown University
- Last updated on ClinicalTrials.gov
- May 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Delaware · 1
- ChristianaCare-Helen F. Graham Cancer Center & Research Institute · Newark, DE
District of Columbia · 1
- Georgetown University · Washington D.C., DC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.